This page shows the latest GAVI news and features for those working in and with pharma, biotech and healthcare.
In October Sanofi/GSK signed an agreement with Gavi, the legal administrator of COVAX, to make 200 million doses of their vaccine available to the facility.
CEPI, along with the World Health Organization and the Gavi vaccines alliance, is co-leading the COVAX facility – an initiative aiming to ensure equitable access to COVID-19 vaccines.
On Friday, Gavi, which is also co-leading COVAX, said that 76 high-income countries have now committed to joining the facility.
Countries have signed intent to joining COVID-19 vaccine initiative. Gavi vaccines alliance’s chief executive Seth Berkley has revealed that 76 high-income countries have now committed to joining the
The COVAX facility is co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO.
The COVAX initiative is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance and the WHO.
More from news
Approximately 6 fully matching, plus 29 partially matching documents found.
At the end of April, Gavi, the Vaccine Alliance, was already reporting vaccine shortages in at least 21 LMICs.
GAVI has not limited itself by handing out vaccines to recipient countries, but is driving co-responsibility through co-funding of vaccines. ... One of GAVI's strategic objectives is shaping the vaccine marketplace. By 2011, 5 out of 10 vaccines
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
for Vaccines and Immunisation (GAVI) and the WHO.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...